BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2170481)

  • 21. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
    Lortholary O; Meyohas MC; Dupont B; Cadranel J; Salmon-Ceron D; Peyramond D; Simonin D
    Am J Med; 1993 Aug; 95(2):177-87. PubMed ID: 8395142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
    Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
    van 't Wout JW; Raven EJ; van der Meer JW
    J Infect; 1990 Mar; 20(2):147-50. PubMed ID: 2156938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
    Goldberg SL; Geha DJ; Marshall WF; Inwards DJ; Hoagland HC
    Clin Infect Dis; 1993 Jun; 16(6):803-5. PubMed ID: 8392389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Itraconazole in the treatment of deep mycoses].
    Viviani MA; Tortorano AM
    Ann Ist Super Sanita; 1987; 23(4):873-7. PubMed ID: 2837939
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case of secondary invasive pulmonary aspergillosis originating from an aspergilloma, successfully treated with itraconazole].
    Nakagawa Y; Shimazu K; Ebihara M; Amann K
    Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):294-8. PubMed ID: 9656680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
    Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation.
    Faggian G; Livi U; Bortolotti U; Mazzucco A; Stellin G; Chiominto B; Vivani MA; Gallucci V
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2506-7. PubMed ID: 2539678
    [No Abstract]   [Full Text] [Related]  

  • 30. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
    Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
    Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of patients with pulmonary aspergilloma with itraconazole].
    Wierzbicka M; Wesolowski S; Podsiadło B; Bestry I
    Pneumonol Alergol Pol; 1996; 64(1-2):59-63. PubMed ID: 8630468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudotumoral naso-sinusal aspergillosis stabilized by itraconazole].
    Gresenguet G; Belec L; Testat J; Lesbordes JL; Dupont B; Georges AJ
    Med Trop (Mars); 1989; 49(1):73-5. PubMed ID: 2542719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
    Moore L; Ellis DH; Suppiah R; Byard RW; Toogood IR
    J Paediatr Child Health; 1993 Apr; 29(2):141-3. PubMed ID: 8387801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with itraconazole in cryptococcosis and aspergillosis.
    Viviani MA; Tortorano AM; Langer M; Almaviva M; Negri C; Cristina S; Scoccia S; De Maria R; Fiocchi R; Ferrazzi P
    J Infect; 1989 Mar; 18(2):151-65. PubMed ID: 2540243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
    Hector RF; Yee E
    Antimicrob Agents Chemother; 1990 Mar; 34(3):448-54. PubMed ID: 2159257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-fungal chemotherapy for symptomatic pulmonary aspergilloma.
    Kawana A; Yamauchi Y; Kudo K
    Jpn J Infect Dis; 2000 Feb; 53(1):29-30. PubMed ID: 10777860
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of deep mycoses with itraconazole.
    Kumar B; Kaur I; Chakrabarti A; Sharma VK
    Mycopathologia; 1991 Sep; 115(3):169-74. PubMed ID: 1660959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of pulmonary aspergilloma with itraconazole.
    Burdon JG; Barnes M; Harris A
    Thorax; 1992 Apr; 47(4):328. PubMed ID: 1316641
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
    Sato A; Nakatani K; Matsushita Y; Matsuo H; Yamadori H; Kurasawa T; Ikeda Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1141-5. PubMed ID: 8544389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.
    Dupont B; Drouhet E
    Rev Infect Dis; 1987; 9 Suppl 1():S71-6. PubMed ID: 3027850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.